A detailed history of Amalgamated Bank transactions in Neuro Pace Inc stock. As of the latest transaction made, Amalgamated Bank holds 472 shares of NPCE stock, worth $5,366. This represents 0.0% of its overall portfolio holdings.

Number of Shares
472
Previous 472 -0.0%
Holding current value
$5,366
Previous $4,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$6.38 - $15.33 $3,011 - $7,235
472 New
472 $4,000
Q2 2022

Aug 15, 2022

SELL
$4.95 - $8.7 $5,722 - $10,057
-1,156 Closed
0 $0
Q1 2022

Jun 30, 2022

BUY
$7.06 - $11.57 $8,161 - $13,374
1,156 New
1,156 $9,000

Others Institutions Holding NPCE

About NeuroPace Inc


  • Ticker NPCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,846,900
  • Market Cap $283M
  • Description
  • NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...
More about NPCE
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.